Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5774050

O=C(CCc1cnoc1-c1ccc(C(F)(F)F)cc1)NCCCN(CCO)CCO.O=C(O)C(F)(F)F

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 6/20 0.43
MAPT P10636 2/20 0.38
FAAH O00519 1/20 0.38
GAA P10253 1/20 0.36
HDAC1 Q13547 5/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC6 Q9UBN7 3/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
ALOX15 P16050 1/20 0.35
HTT P42858 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
TP53 P04637 1/20 0.35
SPHK2 Q9NRA0 1/20 0.35
ACKR3 P25106 1/20 0.34
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5777271 0.92 GAA (0.37) TRPV1MAPTGAAHDAC6ALDH1A1
SCHEMBL5774052 0.90 TRPV1 (0.40) TRPV1MAPTFAAHGAAHDAC1
Trifluoroacetic Acid SCHEMBL5772750 0.86 MAPT (0.40) TRPV1MAPTFAAHGAAALDH1A1
Trifluoroacetic Acid SCHEMBL5776657 0.86 MAPT (0.42) TRPV1MAPTHDAC1HDAC2HDAC6
Trifluoroacetic Acid SCHEMBL5774893 0.84 GAA (0.47) MAPTGAAHDAC2HDAC6ALDH1A1
Trifluoroacetic Acid SCHEMBL5775717 0.82 GSK3B (0.44) TRPV1FAAHTP53FFAR1
Trifluoroacetic Acid SCHEMBL5775554 0.82 HDAC4 (0.43) TRPV1MAPTFAAHHDAC1HDAC6
SCHEMBL5777275 0.82 LMNA (0.33) TRPV1MAPTGAAHDAC1HDAC6
SCHEMBL5774056 0.80 TRPV1 (0.38) TRPV1FAAHHDAC1HDAC2HDAC8
Trifluoroacetic Acid SCHEMBL5772663 0.80 IDE (0.49) HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR TRPV1 2864/4885MAPT 4701/4885FAAH 2848/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 TRPV1 3621/4885MAPT 4763/4885FAAH 1727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.